- Home
- AVIR vs OSUR Comparison
AVIR vs OSUR Comparison
Compare AVIR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- OSUR
- Stock Information
- Founded
- AVIR 2012
- OSUR 2000
- Country
- AVIR United States
- OSUR United States
- Employees
- AVIR N/A
- OSUR N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- OSUR Medical/Dental Instruments
- Sector
- AVIR Health Care
- OSUR Health Care
- Exchange
- AVIR Nasdaq
- OSUR Nasdaq
- Market Cap
- AVIR 284.6M
- OSUR 289.4M
- IPO Year
- AVIR 2020
- OSUR 1986
- Fundamental
- Price
- AVIR $3.24
- OSUR $3.92
- Analyst Decision
- AVIR Hold
- OSUR Hold
- Analyst Count
- AVIR 1
- OSUR 2
- Target Price
- AVIR $6.88
- OSUR $5.50
- AVG Volume (30 Days)
- AVIR 505.9K
- OSUR 914.1K
- Earning Date
- AVIR 02-26-2025
- OSUR 02-25-2025
- Dividend Yield
- AVIR N/A
- OSUR N/A
- EPS Growth
- AVIR N/A
- OSUR N/A
- EPS
- AVIR N/A
- OSUR 0.15
- Revenue
- AVIR N/A
- OSUR $224,263,000.00
- Revenue This Year
- AVIR N/A
- OSUR N/A
- Revenue Next Year
- AVIR N/A
- OSUR N/A
- P/E Ratio
- AVIR N/A
- OSUR $25.69
- Revenue Growth
- AVIR N/A
- OSUR N/A
- 52 Week Low
- AVIR $2.75
- OSUR $3.52
- 52 Week High
- AVIR $4.60
- OSUR $8.04
- Technical
- Relative Strength Index (RSI)
- AVIR 47.81
- OSUR 57.58
- Support Level
- AVIR $3.11
- OSUR $3.52
- Resistance Level
- AVIR $3.49
- OSUR $3.80
- Average True Range (ATR)
- AVIR 0.14
- OSUR 0.14
- MACD
- AVIR -0.00
- OSUR 0.03
- Stochastic Oscillator
- AVIR 26.58
- OSUR 93.02
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.